Ding et al. found endogenous IL-7 to enhance donor CD4+ effector T cell expansion and persistence after lymphodepleting chemotherapy, improving the therapeutic outcome in a mouse lymphoma model [25]. The gene discussed is CD4; the disease is lymphoma.